Formycon AG | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
10,381.20
9,223.90
20,297.20
13,966.90
15,478.30
12,308.50
Total Accounts Receivable
178.10
3,252.40
2,756.90
5,208.90
10,519.20
5,167.80
Inventories
273.40
345.60
232.20
632.10
577.90
1,215.60
Other Current Assets
50.80
54.00
121.10
979.50
56.00
54
Total Current Assets
10,883.50
12,875.80
23,407.40
20,787.30
26,631.30
18,745.80
Net Property, Plant & Equipment
2,986.90
2,688.90
2,606.10
3,409.40
3,255.20
3,472.90
Total Investments and Advances
1,693.00
-
-
-
0.20
15,973.20
Intangible Assets
1,556.50
1,341.60
1,133.80
989.60
858.10
766.80
Other Assets
-
-
-
-
82.70
145.40
Total Assets
17,119.80
16,906.30
27,147.30
25,186.30
30,827.60
39,623.90
ST Debt & Current Portion LT Debt
-
-
-
-
0.80
Accounts Payable
1,293.10
2,270.60
649.20
2,309.10
1,767.20
Income Tax Payable
54.60
-
-
218.70
1,336.00
Other Current Liabilities
150.70
994.30
694.00
1,047.00
901.00
Total Current Liabilities
1,498.40
3,265.00
1,343.10
3,574.90
4,004.90
Provision for Risks & Charges
493.40
530.20
663.90
720.00
1,275.40
Other Liabilities
1,200.00
-
269.30
-
3.80
Total Liabilities
3,191.80
3,795.20
2,276.30
4,294.90
5,284.10
Common Equity (Total)
13,927.90
13,111.10
24,871.00
20,891.40
25,543.50
Total Shareholders' Equity
13,927.90
13,111.10
24,871.00
20,891.40
25,543.50
Total Equity
13,927.90
13,111.10
24,871.00
20,891.40
25,543.50
Liabilities & Shareholders' Equity
17,119.80
16,906.30
27,147.30
25,186.30
30,827.60

About Formycon

View Profile
Address
Fraunhoferstraße 15
Munich Bayern (Bavaria) 82152
Germany
Employees -
Website http://formycon.com
Updated 07/08/2019
Formycon AG engages in the manufacture of biosimilar drugs and formulations. Its product candidates include FYB201, FYB202, FYB203, and FYB205 which focusoin the opthalmology and immunology disease areas. The company was founded by Friedrich Wilhelm Steinweg and Nicolas Combé in 2007 and is headquartered in Munich, Germany.